Liposomal amphotericin B and recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in the treatment of paediatric AIDS-related cryptococcosis.
Manfredi
R
R
Dipartimento di Medicina Clinica Specialistica e Sperimentale, Università di Bologna, Italy.
Coronado
O V
OV
Mastroianni
A
A
Chiodo
F
F
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000503:physiopathology; D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002648:Child; D003453:Cryptococcosis / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D004337:Drug Carriers; D004359:Drug Therapy, Combination; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D008081:Liposomes; D011994:Recombinant Proteins / Q000627:therapeutic use
D000935:Antifungal Agents; D004337:Drug Carriers; D008081:Liposomes; D011994:Recombinant Proteins; D000666:Amphotericin B; D016178:Granulocyte-Macrophage Colony-Stimulating Factor